Health Dictionary Find a Doctor

Immune Thrombocytopenia risk factors

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Maryam Barkhordarian, M.D.[2]

Overview

There are no established risk factors for [disease name].

OR

The most potent risk factor in the development of ITP is [risk factor 1]. Other risk factors include [risk factor 2], [risk factor 3], and [risk factor 4].

OR

Common risk factors in the development of ITP include environmental, genetic and viral. Genetic risk factors includes mutations in single nucleotide polymorphism and variety of interleukins. The most common viral and environmental risk factors include infection with HIV and Helicobacter pylori.

OR

Common risk factors in the development of [disease name] may be occupational, environmental, genetic, and viral.

Risk Factors

There are no established risk factors for [disease name].

OR

The most potent risk factor in the development of [disease name] is [risk factor 1]. Other risk factors include [risk factor 2], [risk factor 3], and [risk factor 4].

OR

Common risk factors in the development of [disease name] include [risk factor 1], [risk factor 2], [risk factor 3], and [risk factor 4].

Common Risk Factors

Less Common Risk Factors

  • Less common risk factors in the development of [disease name] include:
    • [Risk factor 1]
    • [Risk factor 2]
    • [Risk factor 3]

References

  1. Schmoldt A, Benthe HF, Haberland G (1975). “Digitoxin metabolism by rat liver microsomes” Check |url= value (help). Biochem Pharmacol. 24 (17): 1639–41. PMID https://doi.org/10.3389/fimmu.2018.00880 Check |pmid= value (help).
  2. Kohli, Rahil; Chaturvedi, Shruti (2019). “Epidemiology and Clinical Manifestations of Immune Thrombocytopenia”. Hämostaseologie. 39 (03): 238–249. doi:10.1055/s-0039-1683416. ISSN 0720-9355.

Template:WH Template:WS

© 2026 MyEClinic – IFTM Institut für Telematik in der Medizin GmbH